EDGAR Filing Documents for 0001193125-13-181907

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001193125-13-181907

Filing Date

2013-04-29

Accepted

2013-04-29 15:42:59

Documents

Effectiveness Date

2013-04-29

Document Format Files

Seq	Description	Document	Type	Size
1	DEFA14A	d525410ddefa14a.htm	DEFA14A	31718
2	GRAPHIC	g525410defa_pg002a.jpg	GRAPHIC	39505
3	GRAPHIC	g525410defa_pg002b.jpg	GRAPHIC	24038
4	GRAPHIC	g525410defa_pg002c.jpg	GRAPHIC	3647
5	GRAPHIC	g525410defa_pg002d.jpg	GRAPHIC	14837
6	GRAPHIC	g525410defa_pg002e.jpg	GRAPHIC	8193
7	GRAPHIC	g525410defa_pg002f.jpg	GRAPHIC	2239
8	GRAPHIC	g525410defa_pg002g.jpg	GRAPHIC	3665
9	GRAPHIC	g525410defa_pg002h.jpg	GRAPHIC	4116
10	GRAPHIC	g525410defa_pg003.jpg	GRAPHIC	3665
	Complete submission text file	0001193125-13-181907.txt		177364

Mailing Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615

Business Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615 (919) 862-1000

SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-23265 | Film No.: 13791526
SIC: 2834 Pharmaceutical Preparations